Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« IV ferric carboxymaltose tops IV iron sucrose for iron-deficiency anemia in IBD Next Article
No need to adjust rivaroxaban dose for overweight heart disease patients »
« IV ferric carboxymaltose tops IV iron sucrose for iron-deficiency anemia in IBD Next Article
No need to adjust rivaroxaban dose for overweight heart disease patients »
Related Articles
June 25, 2019
Treatment options in early NSCLC
November 26, 2019
Ceritinib in ALK+ NSCLC brain metastases
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy